Average Insider

Where insiders trade, we follow

InMed Pharmaceuticals Inc. ($INM)
Accession: 0001213900-26-078891
Jul 17, 2026
๐Ÿ“ˆ Chart on TradingView๐Ÿ’ฐ Financials on Finviz
52W Low$0.57
Current$1.5243.4% above low, 56.6% below high
52W High$2.75

Filing Information

Accession Number0001213900-26-078891
Form Type4
Filing DateJul 17, 2026
DocumentView SEC Filing
Transactions
6
Total Shares
20,546
Total Value
$31,846.30
P&L
-1.9% ($616.38)

Transactions

NameTitleSecurityDerivativeTransaction DateTypeSharesPriceTotal CostShares AfterDirect/IndirectNature of OwnershipActions
Vivo Opportunity, LLC
10% Owner
Common Shares
โ€”Jul 14, 2026Purchase4,882$1.55$7,567.10729,277IndirectBy Vivo Opportunity Fund Holdings, L.P.View Details
Vivo Opportunity, LLC
10% Owner
Common Shares
โ€”Jul 14, 2026Purchase493$1.55$764.1573,628IndirectBy Vivo Opportunity Cayman Fund, L.P.View Details
Vivo Opportunity, LLC
10% Owner
Common Shares
โ€”Jul 15, 2026Purchase13,761$1.55$21,329.55743,038IndirectBy Vivo Opportunity Fund Holdings, L.P.View Details
Vivo Opportunity, LLC
10% Owner
Common Shares
โ€”Jul 15, 2026Purchase1,389$1.55$2,152.9575,017IndirectBy Vivo Opportunity Cayman Fund, L.P.View Details
Vivo Opportunity, LLC
10% Owner
Common Shares
โ€”Jul 16, 2026Purchase19$1.55$29.45743,057IndirectBy Vivo Opportunity Fund Holdings, L.P.View Details
Vivo Opportunity, LLC
10% Owner
Common Shares
โ€”Jul 16, 2026Purchase2$1.55$3.1075,019IndirectBy Vivo Opportunity Cayman Fund, L.P.View Details
Version: v26.7.3